Biller Jonathan sold VRTX
October 2, 2025 · Form 4 insider transaction
Biller Jonathan sold 694 shares of Vertex Pharmaceuticals Incorporated at $404.21 per share, a transaction worth $280.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
694
Price
$404.21
Total value
$280.5K
InsiderBiller Jonathan
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 2, 2025
Filing dateOctober 3, 2025
Shares owned after15,653
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/24/2025.